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Background
Aspergillus niger has a long history as a producer of food-
grade enzymes and is established as a GRAS (Generally
Recognized As Safe) organism. As Chymosin has been cre-
ated by nature to coagulate cow's milk, it is not surprising
that chymosin is the most commonly used enzyme for
cheesemaking. Since more than 10 years Chr. Hansen is
producing chymosin by a large scale fermentation proc-
ess.
Results
The genome of A. niger was modified by inserting a pro-
chymosin c-DNA via an expression vector. Chymosin is
secreted as a fusion protein with glucoamylase and proc-
essed to the active protein during fermentation. After cul-
tivation the biomass is inactivated by lowering the pH-
value and separated by filtration. For concentration and
purification of chymosin a one-step EBA (Expanded Bed
Adsorption) chromatography is used. This new produc-
tion process is illustrated in Figure 1.
During the last years the fermentation process was opti-
mised by changing various parameters like feeding strat-
egy and inoculation procedure of the Seed fermentor. The
concentration step with an aqueous two-phase system
with PEG (poly-ethylen-glycol) and the purification step
with an ion-exchange chromatography step were replaced
by one-step EBA chromatography.
Conclusion
The simplified downstream process reduced the costs for
waste water treatment and increased the recovery yield.
Due to its high quality, the unlimited availability and its
competitiveness to other milk clotting enzymes the mar-
ket share of fermentation produced chymosin (FPC)
increased significantly over the last years.
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